Ana S. Cerdeira

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Evaluation of analytical performance of the Revvity sFlt-1 and PlGF methods for the assessment of preeclampsia.

Evaluation of analytical performance of the Revvity sFlt-1 and PlGF methods for the assessment of preeclampsia.

Journal: British journal of biomedical science

Published: November 25, 2025

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Journal: Nature medicine

Published: September 05, 2025

Considerations for gestational age, delivery indication, and therapies in preeclampsia prediction.

Considerations for gestational age, delivery indication, and therapies in preeclampsia prediction.

Journal: American journal of obstetrics and gynecology

Published: April 30, 2025

Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan.

Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: February 26, 2025

Acute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report.

Acute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report.

Journal: Clinical case reports

Published: January 16, 2025

Soluble fms-like tyrosine kinase 1-to-placental growth factor ratio predicts time to delivery and mode of birth.

Soluble fms-like tyrosine kinase 1-to-placental growth factor ratio predicts time to delivery and mode of birth.

Journal: American journal of obstetrics and gynecology

Published: July 07, 2024

Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.

Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.

Journal: Lancet (London, England)

Published: March 03, 2024

The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.

The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.

Journal: American journal of obstetrics and gynecology

Published: November 24, 2023

Serial placental growth factor-based testing in pre-eclampsia.

Serial placental growth factor-based testing in pre-eclampsia.

Journal: Lancet (London, England)

Published: October 29, 2023

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia.

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia.

Journal: Frontiers in cardiovascular medicine

Published: October 04, 2023

Novel therapeutic and diagnostic approaches for preeclampsia.

Novel therapeutic and diagnostic approaches for preeclampsia.

Journal: Current opinion in nephrology and hypertension

Published: January 23, 2023

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: A historical cohort study.

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: A historical cohort study.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: September 22, 2022

Showing 1-12 of 53

Last Updated: 09/26/2026